molgramostim
Generic: granulocyte-macrophage colony-stimulating factor
molgramostim: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Savara Inc (SVRA) | Phase 3 |
Clinical Trials (1)
An Open-label, Multicenter Clinical Study to Evaluate the Efficacy and Safety of Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
Frequently asked questions
Who is developing molgramostim?
molgramostim is being developed by Savara Inc.
How many clinical trials involve molgramostim?
BioSniper tracks 1 clinical trial involving molgramostim.
Get deeper analysis on molgramostim
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis